|

Multiple Sclerosis Clinical Trials in Denver, CO

15 recruiting studies within 50 miles

Phase
Trial Phase Dist.
TSC Biosample Repository and Natural History Database—<1 mi
A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101—<1 mi
A Study Evaluating the Real World Experience of Participants Treated With BRIUMVI® (Ublituximab-xiiy) for Relapsing Multiple Sclerosis (RMS)—<1 mi
Stopping TSC Onset and Progression 2B: Sirolimus TSC Epilepsy Prevention StudyPhase 28 mi
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical IllnessesPhase 28 mi
Prospective Evaluation of Sequencing From antiCD-20 Therapies to OzanimodPhase 48 mi
A Study to Evaluate the Efficacy, Safety and Tolerability of BMS-986368 in Participants With Multiple Sclerosis SpasticityPhase 28 mi
Best Available Therapy Versus Autologous Hematopoietic Stem Cell Transplant for Multiple Sclerosis (BEAT-MS)Phase 38 mi
Pregnancy Exposure Registry for Vumerity (Diroximel Fumarate)—8 mi
Care in Multiple Sclerosis (MS)—8 mi
Blood Flow Restriction And Veterans With MSN/A8 mi
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple SclerosisPhase 38 mi
An Open-label Study of AZD0120 in Adults With Multiple SclerosisPhase 18 mi
Home Based Infusions for OcrelizumabPhase 413 mi
Reducing Fatigue in People With Multiple Sclerosis by Treatment With TENSN/A24 mi

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.